KDIGO grades acute kidney injury into stages 1, 2 and 3 by the rise in serum creatinine and by urine output. Use whichever criterion gives the higher stage. Starting kidney replacement therapy always means stage 3.
Diagnosis first
Stage only once AKI is present: a creatinine rise of at least 0.3 mg/dL (26.5 µmol/L) within 48 hours, a rise to at least 1.5 times baseline within the prior 7 days, or urine output below 0.5 mL/kg/h for 6 hours. See the AKI guide for causes and evaluation.
The KDIGO stages
| Stage | Serum creatinine | Urine output |
|---|---|---|
| 1 | 1.5–1.9 times baseline, or a rise of ≥0.3 mg/dL (≥26.5 µmol/L) | <0.5 mL/kg/h for 6–12 hours |
| 2 | 2.0–2.9 times baseline | <0.5 mL/kg/h for ≥12 hours |
| 3 | 3.0 times baseline or more, or a rise to ≥4.0 mg/dL (≥353.6 µmol/L), or starting kidney replacement therapy, or in patients under 18, eGFR falling below 35 mL/min/1.73 m² | <0.3 mL/kg/h for ≥24 hours, or anuria for ≥12 hours |
How to apply it
- Baseline creatinine: use the most recent stable value before admission. Without one, the lowest value during the admission is often used, and the stage may be revised as results come in.
- Higher stage wins: when creatinine and urine output point to different stages, report the higher one.
- Urine output is weight-based: divide hourly output by body weight in kilograms.
- Units: creatinine in µmol/L divided by 88.4 gives mg/dL.
Worked examples
- Baseline creatinine 1.0 mg/dL, now 2.3 mg/dL: 2.3 times baseline, stage 2.
- Creatinine 0.8 mg/dL rising to 1.2 mg/dL within 48 hours: a rise of 0.4 mg/dL and 1.5 times baseline, stage 1.
- Baseline 1.6 mg/dL, now 4.2 mg/dL: 2.6 times baseline, but above 4.0 mg/dL, stage 3.
- A 70 kg patient passing 25 mL/h for 8 hours: 0.36 mL/kg/h for 6–12 hours, stage 1 by urine output.
- Any patient started on haemodialysis or CRRT for AKI: stage 3.
Why the stage matters
Higher stages carry higher risk of dialysis need, longer stay, death and later chronic kidney disease. KDIGO links management to the stage: stop nephrotoxins and keep volume and perfusion adequate from stage 1, consider dose changes and closer monitoring from stage 2, and consider kidney replacement therapy in stage 3 when complications demand it.
Staging and EGYAKIN
EGYAKIN does not calculate the KDIGO stage automatically. Its AKI registry records the inputs the staging needs: creatinine on admission and daily to day 10, urine output, and whether dialysis was started, with modality, indication and number of sessions. It calculates eGFR by CKD-EPI 2021 with the KDIGO GFR category, which is a different classification used for chronic kidney disease.
References
- KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney International Supplements 2012;2(1):1–138.
- Kellum JA, Lameire N; KDIGO AKI Guideline Work Group. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Critical Care 2013;17(1):204.
This guide summarises published guidelines for doctors. It is not a substitute for clinical judgement or the full guideline text.